Roche, in collaboration with KlinRisk, Inc, has received CE-mark for the first AI-based risk stratification tool for assessment of progressive decline in kidney function. This tool will be launched as ...
This is Part 6 of Embedded Bias, a series revealing how race-based clinical algorithms pervade medicine and why it's so difficult to change them. NEW YORK — One Brooklyn Health, a safety net hospital ...
For patients with the triad of chronic kidney disease, type 2 diabetes, and hypertension, the use of an electronic health record-based algorithm and intervention does not result in reduced ...
Roche Holdings AG received CE-mark for the Kidney Klinrisk algorithm, an AI-based tool developed in collaboration with Klinrisk Inc. to stratify risk and assess the progressive decline in kidney ...
AI's role is to support clinical judgment by providing early risk assessments, enabling proactive interventions and a shift ...
For years, it was harder for Black patients to secure a coveted spot on the national kidney transplant waitlist because a clinical algorithm was making Black patients appear healthier than they were.
For years, it was harder for Black patients to secure a coveted spot on the national kidney transplant waitlist because a clinical algorithm was making Black patients appear healthier than they were.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results